Virtual health: What's on the horizon for telehealth and remote monitoring?

As the world responds to the COVID-19 pandemic, physicians and patients are increasingly turning to virtual health solutions, including telehealth and remote monitoring, as a central facet...

Legal Issues in Companion Diagnostics

On January 23rd, members of the Hogan Lovells Global Regulatory Health Care and FDA practice group will provide an in-depth presentation focused on Companion Diagnostics (CDx). The program...

Silicon Valley: Life Sciences and Health Care Horizons 2019

Join us in Silicon Valley: Local insights for global reach

Tokyo: Life Sciences and Health Care Horizons 2019

Key Life Sciences issues for Japanese companies: focus on (1) digital health, (2) cell, tissue, and gene therapies, and (3) cross-border transactions.

Sydney: Join leaders from Hogan Lovells Medical Device team for conversation and cocktails

We welcome you to join members of our medical device and health care regulatory team as we discuss how to navigate the shifting regulatory landscape facing medical device firms. From...

AusMedTech 2019

AusMedTech 2019 brought together knowledgeable speakers and panelists to share insight on a range of topics falling under the theme of "Bionics and beyond."

The impact of Brexit on the pharmaceutical and medical device industries

Our European Life Sciences Regulatory team has been examining the potential consequences of Brexit for the pharmaceutical and medical device industries since before the results of the...

Life Sciences BREXIT Countdown

We have been examining the potential consequences of BREXIT for the pharmaceutical and medical device industries since before the results of the referendum were known. We are working with...

Loading data